SCHEMBL9492441

SCHEMBL9492441

COc1ccc(OC)c(C2(OC(=O)C(=O)O)CN3CCC2CC3)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
HTR2C P28335 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
POLB P06746 1/20 0.39
MMP2 P08253 2/20 0.38
MMP13 P45452 2/20 0.38
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
HTR3A P46098 1/20 0.37
TSHR P16473 2/20 0.37
KDM2B Q8NHM5 3/20 0.36
NPSR1 Q6W5P4 1/20 0.36
NPC1 O15118 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9492737 0.91 CHRM2 (0.42) CHRM2CHRM4CHRM5CHRM1CHRM3
Oxalic Acid SCHEMBL9492436 0.81 CHRM2 (0.62) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9494634 0.81 SLC6A2 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9495675 0.81 ALDH1A1 (0.46) MEN1KMT2AMMP13ALDH1A1
SCHEMBL9496244 0.80 CHRM2 (0.50) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9492346 0.77 CHRM1 (0.69) CHRM2CHRM4CHRM5CHRM1CHRM3
Oxalic Acid SCHEMBL9492735 0.74 CHRM2 (0.62) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9493463 0.73 SLC6A4 (0.50) MEN1KMT2AALDH1A1KDM2B
SCHEMBL9493558 0.69 CHRM1 (0.69) CHRM2CHRM4CHRM5CHRM1CHRM3
Oxalic Acid SCHEMBL9494462 0.67 KMT2A (0.59) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5177084-A 1-Azabicycles, Treating Mental Disorders MERCK SHARP & DOHME LTD. (GB) 1993-01-05 US disclosed
EP-0412797-A2 The therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes MERCK SHARP & DOHME LTD. (GB) 1991-02-13 EP disclosed